50岁女性局限性硬皮病合并间质性肺病与肺动脉高压的急性加重
一例50岁女性,有局限性硬皮病(SSc)病史,并发间质性肺病(ILD)和肺动脉高压(PAH)。10年前诊断SSc,2年前发现ILD并接受霉酚酸酯和低剂量泼尼松治疗。1年前出现劳力性呼吸困难加重(NYHA III级),需补充氧气最多5 L,右心导管检查显示严重PAH:右房压19 mm Hg,肺动脉压98/39 mm Hg(平均58 mm Hg),右室压59/6 mm Hg,肺动脉楔压10 mm Hg,心输出量4.2 L/min,心脏指数2.7 L/min/m2,肺血管阻力11.43 Wood单位;吸入一氧化氮试验无显著血管反应性。开始静脉曲普前列素治疗并上调剂量6个月后因急性加重的慢性呼吸困难就诊。
要点
- SSc患者应筛查ILD和PAH,PAH可独立于ILD进展。
- 右心导管是确诊PAH的金标准,本例示严重血流动力学异常。
- 吸入一氧化氮无反应提示非血管反应性PAH,需靶向药物治疗。
核心结论
- 本例为SSc相关PAH合并ILD,急性加重需评估PAH进展及并发症。
研究设计与样本
- 单例病例报告,来自Chest的临床病例挑战。
主要发现
- 右心导管显示右房压19 mm Hg,肺动脉压98/39 mm Hg(平均58 mm Hg),右室压59/6 mm Hg,肺动脉楔压10 mm Hg,心输出量4.2 L/min,心脏指数2.7 L/min/m2,肺血管阻力11.43 Wood单位。
- 吸入一氧化氮挑战无显著血管反应性。
- 接受静脉曲普前列素治疗并上调剂量6个月。
临床怎么用
- SSc患者出现呼吸困难加重应评估PAH,右心导管明确诊断和严重程度。
- 无血管反应性者需PAH靶向治疗,静脉曲普前列素为选择之一。
局限性
- 单例报告,结论不能推广至所有SSc-PAH患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 50-year-old woman with a medical history significant for limited scleroderma (SSc) complicated by interstitial lung disease (ILD) and pulmonary arterial hypertension presented to our institution with acute on chronic shortness of breath. Ten years before presentation, she was diagnosed with SSc. Two years before presentation, she was found to have ILD, for which she was started on mycophenolate mofetil and low-dose prednisone. One year before presentation, she noted worsening dyspnea on exertion (New York Heart Association Functional Class III) and required supplemental oxygen, up to 5 L, despite findings of stable ILD on a maintenance dose of mycophenolate mofetil. A subsequent right heart catheterization showed findings consistent with severe pulmonary arterial hypertension: right atrial pressure of 19 mm Hg, pulmonary arterial pressure of 98/39 mm Hg with a mean pulmonary arterial pressure of 58 mm Hg, right ventricular pressure of 59/6 mm Hg, pulmonary arterial wedge pressure of 10 mm Hg, cardiac output of 4.2 L/min with a cardiac index of 2.7 L/min/m2, and a calculated pulmonary vascular resistance of 11.43 Wood units. She had no significant vasoreactivity on inhaled nitric oxide challenge. She was started on IV treprostinil that had been up-titrated over the course of 6 months before presentation. On admission, she denied any cough, fevers, chills, chest pains, palpitations, or lower extremity edema. She denied any sick contacts or any recent travel. She denied any periods of prolonged immobility.
引用
- Walia A, Singh I, Ryu C, et al. A 50-Year-Old Woman With Limited Scleroderma Presenting With Shortness of Breath. Chest. 2020. PMID: 32654737. doi:10.1016/j.chest.2020.02.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。